ArticleFrontiers in immunology2017

Targeting Multiple Tumors Using T-Cells Engineered to Express a Natural Cytotoxicity Receptor 2-Based Chimeric Receptor.

Vasyl Eisenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.